Literature DB >> 2295230

Long-term reproducibility of respiratory gas exchange measurements during exercise in patients with stable cardiac failure.

J S Janicki1, S Gupta, S T Ferris, P A McElroy.   

Abstract

Present-day technology has greatly facilitated the monitoring of respiratory gas exchange in the clinical exercise laboratory. Despite the growing use of these techniques to assess the severity and progression of disease or therapeutic response in patients with heart failure, the long-term reproducibility of oxygen uptake (VO2), carbon dioxide production, minute ventilation, heart rate (HR), and blood pressure at rest and during incremental exercise in such patients, to our knowledge, has not been evaluated. Therefore, the purpose of this study was to quantify the reproducibility of these variables along with exercise duration, maximum VO2 (VO2max) and anaerobic threshold in a group of 16 patients (61 +/- 7 years, 14 male) with chronic, stable cardiac failure of varying severity and etiology who had five or more incremental treadmill exercise tests over a period of time that ranged from 3 to 22 months. For each variable, reproducibility was represented by the coefficient of variation (CVAR). Except for exercise duration, CVAR was not a function of the severity of heart failure and, for all variables, patient-to-patient variation in CVAR was approximately 9 percent. The maximum CVAR for HR, systolic blood pressure, VO2, and VO2max was generally below 10.5 percent and for exercise duration and anaerobic threshold it was less than 12.5 percent. Based on this retrospective analysis, it is concluded that reproducible respiratory gas exchange and HR exercise responses are obtainable over extended periods of time in patients with stable, chronic cardiac failure. Exercise duration, however, is less reproducible in patients with moderate to severe failure.

Entities:  

Mesh:

Year:  1990        PMID: 2295230     DOI: 10.1378/chest.97.1.12

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  10 in total

Review 1.  Automated metabolic gas analysis systems: a review.

Authors:  D J Macfarlane
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

2.  Effects of atenolol, slow-release nifedipine, and their combination on respiratory gas exchange and exercise tolerance in stable effort angina.

Authors:  S Wieshammer; M Hetzel; U Barnikel; M Höher; H Seibold; M Kochs; V Hombach
Journal:  Klin Wochenschr       Date:  1991-09-16

3.  Reproducibility of onset and recovery oxygen uptake kinetics in moderately impaired patients with chronic heart failure.

Authors:  Hareld M C Kemps; Wouter R De Vries; Adwin R Hoogeveen; Maria L Zonderland; Eric J M Thijssen; Goof Schep
Journal:  Eur J Appl Physiol       Date:  2007-02-03       Impact factor: 3.078

4.  Reliability of maximal cardiopulmonary exercise testing in men with prostate cancer.

Authors:  Jessica M Scott; Whitney E Hornsby; Amy Lane; Aarti A Kenjale; Neil D Eves; Lee W Jones
Journal:  Med Sci Sports Exerc       Date:  2015-01       Impact factor: 5.411

5.  Reproducibility of incremental maximal cycle ergometer testing in patients with restrictive lung disease.

Authors:  D D Marciniuk; R E Watts; C G Gallagher
Journal:  Thorax       Date:  1993-09       Impact factor: 9.139

6.  Oxygen uptake kinetics during low level exercise in patients with heart failure: relation to neurohormones, peak oxygen consumption, and clinical findings.

Authors:  H P Brunner-La Rocca; D Weilenmann; F Follath; M Schlumpf; H Rickli; C Schalcher; F E Maly; R Candinas; W Kiowski
Journal:  Heart       Date:  1999-02       Impact factor: 5.994

7.  Prolonged mean VO2 response time in systolic heart failure: an indicator of impaired right ventricular-pulmonary vascular function.

Authors:  Neal A Chatterjee; Ryan M Murphy; Rajeev Malhotra; Bishnu P Dhakal; Aaron L Baggish; Paul P Pappagianopoulos; Stacyann S Hough; Marc J Semigran; Gregory D Lewis
Journal:  Circ Heart Fail       Date:  2013-04-09       Impact factor: 8.790

8.  Oxygen kinetics during 6-minute walk tests in patients with cardiovascular and pulmonary disease.

Authors:  Lukas Kern; Sophie Condrau; Florent Baty; Jan Wiegand; Arno J R van Gestel; Andrea Azzola; Michael Tamm; Martin Brutsche
Journal:  BMC Pulm Med       Date:  2014-10-29       Impact factor: 3.317

9.  Inability of myalgic encephalomyelitis/chronic fatigue syndrome patients to reproduce VO₂peak indicates functional impairment.

Authors:  Betsy A Keller; John Luke Pryor; Ludovic Giloteaux
Journal:  J Transl Med       Date:  2014-04-23       Impact factor: 5.531

10.  Cardiopulmonary Exercise Test Methodology for Assessing Exertion Intolerance in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Authors:  Staci Stevens; Chris Snell; Jared Stevens; Betsy Keller; J Mark VanNess
Journal:  Front Pediatr       Date:  2018-09-04       Impact factor: 3.418

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.